Gamma-aminobutyric acid type A receptor alpha-1 subunit-containing subtypes (GABA-A receptor α1)

The GABA-A receptor alpha-1 subunit-containing subtypes are pentameric ligand-gated chloride channels that represent the most prevalent GABA-A receptor isoform in the mammalian brain (UniProt: P14867). These receptors play a critical role in mediating fast inhibitory neurotransmission by allowing chloride ions to flow into neurons upon activation by gamma-aminobutyric acid (GABA) (StatPearls: Physiology, GABA Receptor). The alpha-1 subunit is specifically associated with the sedative, hypnotic, and anticonvulsant properties of many clinical agents, distinguishing it from other alpha subunits that may mediate anxiolytic or cognitive effects (PMID: 21654834). In disease states, alterations in alpha-1 expression or function are linked to conditions such as epilepsy and insomnia (PubMed: 30103115). Drugs targeting these receptors, such as benzodiazepines and non-benzodiazepine hypnotics like zolpidem, typically act as positive allosteric modulators to enhance inhibitory tone (PubChem: CID 5732). While highly effective for acute treatment, chronic use can lead to tolerance, dependence, and side effects like motor incoordination due to the widespread distribution of the alpha-1 subunit in the central nervous system (PMID: 11689393).

Other names

GABRA1GABA(A) receptor subunit alpha-1Alpha-1 GABA-A receptorGABA-A receptor alpha-1 subunitGABA-A receptor alpha-1

Positive allosteric modulation of the GABA-A receptor complex, specifically at the alpha-1/gamma-2 interface, which increases the frequency of chloride channel opening in the presence of GABA, resulting in hyperpolarization of the neuronal membrane (PMID: 21654834).